Grace Dy
MD
Professor
👥Biography 个人简介
Grace Dy has contributed to lung cancer clinical research, particularly the development of KRAS G12C inhibitors in NSCLC. Her contributions to clinical trials of adagrasib and sotorasib in KRAS G12C-mutant NSCLC, and her research on combination strategies to improve and extend KRAS inhibitor responses, address an important emerging targeted therapy in the most common lung cancer driver mutation.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-03-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Drew M. Pardoll
Johns Hopkins University
Padmanee Sharma
MD Anderson Cancer Center
Naiyer A. Rizvi
Columbia University Irving Medical Center
关注 Grace Dy 的研究动态
Follow Grace Dy's research updates
留下邮箱，当我们发布与 Grace Dy（Roswell Park Comprehensive Cancer Center）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment